Article info

Original article
Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive pulmonary disease: a randomised clinical trial
Free

Authors

  1. Correspondence to Dr Lisa F Tan, Department of Clinical Research, Pfizer Global Research and Development, Field House, Field Road, Kingston, Cambridge CB23 2NQ, UK; lisa.tan{at}pfizer.com
View Full Text

Citation

MacNee W, Allan RJ, Jones I, et al
Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive pulmonary disease: a randomised clinical trial

Publication history

  • Received September 17, 2012
  • Revised March 1, 2013
  • Accepted March 4, 2013
  • First published March 28, 2013.
Online issue publication 
July 09, 2013

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.